We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI
GPGI
+$11M
2
CTIC
CTI BioPharma
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Sector Composition

Rank Sector Weight
1 Healthcare 19.74%
2 Miscellaneous 15.57%
3 Industrials 15.14%
4 Financials 14.94%
5 Materials 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$126B
$85.8M 15.23%
475,000
– –
2019 Q4
9 quarters
LIN icon
2
Linde
LIN
$234B
$61.5M 10.92%
192,627
– –
2019 Q4
9 quarters
BC icon
3
Brunswick
BC
$4.84B
$50.6M 8.97%
625,000
+62,500
+11% +$5.76M
2020 Q1
8 quarters
INVE icon
4
INVE Technologies
INVE
$64.2M
$38.6M 6.85%
2,387,936
+191,547
+9% +$3.68M
2019 Q4
9 quarters
IVAC icon
5
DELISTED
Intevac
IVAC
$26.5M 4.7%
4,949,355
– –
2019 Q4
9 quarters
PACX
6
DELISTED
Pioneer Merger Corp
PACX
$20.8M 3.7%
2,125,000
– –
2021 Q2
3 quarters
CTIC
7
DELISTED
CTI BioPharma
CTIC
$18M 3.2%
3,859,707
+3,609,707
+1,444% +$10.8M
2021 Q4
1 quarter
DRRX icon
8
DELISTED
DURECT Corp
DRRX
$17.7M 3.14%
2,641,466
– –
2019 Q4
9 quarters
SPGI icon
9
S&P Global
SPGI
$129B
$16.4M 2.91%
40,000
– –
2019 Q4
9 quarters
MDXH icon
10
MDxHealth
MDXH
$14M
$16.3M 2.88%
1,958,333
– –
2021 Q4
1 quarter
MRNS icon
11
DELISTED
Marinus Pharmaceuticals
MRNS
$12.4M 2.19%
1,322,463
+259,963
+24% +$2.58M
2020 Q1
8 quarters
CORS
12
DELISTED
Corsair Partnering Corp
CORS
$12.1M 2.15%
1,250,000
– –
2021 Q3
2 quarters
TV icon
13
Televisa
TV
$2.35B
$11.7M 2.08%
1,000,000
+500,000
+100% +$5.18M
2021 Q2
3 quarters
GPGI icon
14
GPGI
GPGI
$3.83B
$11.2M 1.99%
+1,776,008
New +$11M
2022 Q1
0 quarters
LSXMK icon
15
DELISTED
Liberty Media Series C Liberty SiriusXM
LSXMK
$10.8M 1.92%
305,187
– –
2019 Q4
9 quarters
BX icon
16
Blackstone
BX
$91.4B
$10.2M 1.8%
80,000
– –
2019 Q4
9 quarters
ISLE
17
DELISTED
Isleworth Healthcare Acquisition Corp
ISLE
$9.9M 1.76%
1,000,000
– –
2021 Q1
4 quarters
TCDA
18
DELISTED
Tricida
TCDA
$9.9M 1.75%
1,198,400
-168,953
-12% -$1.53M
2021 Q3
2 quarters
OPTN icon
19
DELISTED
OptiNose
OPTN
$9.24M 1.64%
249,479
+1,466
+0.6% +$52.3K
2021 Q4
1 quarter
THO icon
20
Thor Industries
THO
$3.98B
$9.03M 1.6%
114,753
+5,000
+5% +$460K
2020 Q1
8 quarters
DUOT icon
21
Duos Technologies
DUOT
$106M
$7.06M 1.25%
1,283,162
+829,546
+183% +$4.54M
2020 Q1
8 quarters
HLTH icon
22
DELISTED
Cue Health
HLTH
$6.45M 1.14%
1,000,000
– –
2021 Q3
2 quarters
LIQT icon
23
LiqTech
LIQT
$6.92M
$5.29M 0.94%
270,119
-1,875
-0.7% -$81.4K
2020 Q1
8 quarters
IDN icon
24
Intellicheck
IDN
$36.1M
$5.29M 0.94%
2,073,583
– –
2019 Q4
9 quarters
BRFH icon
25
Barfresh Food Group
BRFH
$11.7M
$4.98M 0.88%
+725,288
New +$4.26M
2022 Q1
0 quarters

Similar funds

Bleichroeder's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

  • Bleichroeder's largest Q1 2022 buy was GPGI: 1,776,008 shares worth $11.2M.
  • Bleichroeder added most to CTI BioPharma in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder's biggest Q1 2022 reduction was Tricida, cutting an estimated $1.53M.
  • Bleichroeder fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder's 13F filing for Q1 2022, filed 11 May 2022.